Michael Krueger

Title: Michael Krueger: Innovator in Neurotoxin Detection

Introduction

Michael Krueger is a notable inventor based in Emmendingen, Germany. He has made significant contributions to the field of biotechnology, particularly in the detection of neurotoxins. His work is essential for ensuring safety in various applications, including food safety and medical diagnostics.

Latest Patents

Michael Krueger holds a patent for an "Assay for Clostridium botulinum neurotoxin." This invention relates to materials and methods suitable for determining the presence or amount of Botulinum toxin (BoNT) in a test sample. The assay utilizes a luminescence method, where the substrate peptide is specifically designed for this purpose. He has 1 patent to his name, showcasing his innovative approach to addressing critical health concerns.

Career Highlights

Throughout his career, Michael has worked at prestigious institutions, including Albert-Ludwigs-Universität Freiburg. His research has focused on developing methods that enhance the detection of harmful substances, contributing to public health and safety.

Collaborations

Michael has collaborated with notable colleagues such as Gregory Stevens and Andrea Zgaga-Griesz. These partnerships have fostered a collaborative environment that promotes innovation and the advancement of scientific knowledge.

Conclusion

Michael Krueger's work in the field of neurotoxin detection exemplifies the importance of innovation in biotechnology. His contributions are vital for improving safety standards and advancing research in this critical area.